Cargando…
Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma
BACKGROUND/AIMS: We evaluated changes in liver function parameters and risk factors for the deterioration of liver function 12 months after percutaneous radiofrequency ablation (RFA) therapy in patients with hepatocellular carcinoma (HCC). METHODS: The subjects in this retrospective study comprised...
Autores principales: | Lee, Hyun Seok, Park, Soo Young, Kim, Sung Kook, Kweon, Young Oh, Tak, Won Young, Cho, Chang Min, Jeon, Seong Woo, Jung, Min Kyu, Park, Hyun Gu, Lee, Dong Wook, Choi, So Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467434/ https://www.ncbi.nlm.nih.gov/pubmed/23091811 http://dx.doi.org/10.3350/cmh.2012.18.3.302 |
Ejemplares similares
-
A case of hemocholecyst associated with hemobilia following radiofrequency ablation therapy for hepatocellular carcinoma
por: Shin, Keun Young, et al.
Publicado: (2011) -
Percutaneous portal vein embolization for intractable hepatic biloma after radiofrequency ablation
por: Cha, Jung Guen, et al.
Publicado: (2020) -
Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022) -
No-Touch Radiofrequency Ablation for Early Hepatocellular Carcinoma: 2023 Korean Society of Image-Guided Tumor Ablation Guidelines
por: Han, Seungchul, et al.
Publicado: (2023) -
Noninvasive Fibrosis Marker Can Predict Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
por: Chung, Hyun Ah, et al.
Publicado: (2016)